04.30.24
Two major dietary supplement retailers are taking steps to address growing demand for new GLP-1 agonist medications.
GNC announced it is redesigning more than 2,300 U.S. retail stores by adding an entire section of curated products dedicated to health needs of consumers taking GLP-1 agonist drugs. Initial focus areas include GI health, muscle-mass retention, bone health, and more.
Meanwhile, the New York Times reported that The Vitamin Shoppe has partnered with telehealth company WellSync to fill prescriptions for GLP-1 drugs through a subscription service.
Further Reading: The Ozempic Effect: How the Rise of GLP-1 Drugs May Influence the Nutraceuticals World
It is estimated that 130 million Americans currently live with a condition eligible to be treated with a GLP-1 agonist, and that up to 70 million Americans may use a GLP-1 agonist by 2028.
GNC said its new support program is designed to provide “a holistic supportive experience” for people on GLP-1 drugs.
“Today, we’re staying on the forefront by supporting the millions of people around the world who are on a medical weight loss journey,” GNC CEO Michael Costello said in a press release. “The results of GLP-1 agonists are truly life-changing, but we also know that lifestyle and nutrition support are necessary companions to achieving long-term success. GNC is here to be the helping hand with our knowledgeable coaches in our stores, our science-backed products, and expert education and resources on GNC.com.”
GNC also said its in-store “coaches” have received training related to the common side effects experienced by GLP-1 agonist users, and will continue to get training from the company’s in-house team of RDs and science experts.
The most reported side effect of GLP-1 drugs is a gastrointestinal issue like nausea or constipation.
The GNC support program extends to its website where consumers can find advice and health information fitness and resistance training, healthy recipes, meal plans, and more.
“The market is constantly evolving and at GNC, we are leading the way in product strategy and development to help our customers achieve their wellness goals especially for GLP-1 users,” said Rachel Jones, senior vice president, chief product innovation and science officer, GNC. “We’re not only responding to immediate needs but also continuously collaborating with medical experts to refine and expand our offerings to best serve our customers.”
GNC announced it is redesigning more than 2,300 U.S. retail stores by adding an entire section of curated products dedicated to health needs of consumers taking GLP-1 agonist drugs. Initial focus areas include GI health, muscle-mass retention, bone health, and more.
Meanwhile, the New York Times reported that The Vitamin Shoppe has partnered with telehealth company WellSync to fill prescriptions for GLP-1 drugs through a subscription service.
Further Reading: The Ozempic Effect: How the Rise of GLP-1 Drugs May Influence the Nutraceuticals World
It is estimated that 130 million Americans currently live with a condition eligible to be treated with a GLP-1 agonist, and that up to 70 million Americans may use a GLP-1 agonist by 2028.
GNC said its new support program is designed to provide “a holistic supportive experience” for people on GLP-1 drugs.
“Today, we’re staying on the forefront by supporting the millions of people around the world who are on a medical weight loss journey,” GNC CEO Michael Costello said in a press release. “The results of GLP-1 agonists are truly life-changing, but we also know that lifestyle and nutrition support are necessary companions to achieving long-term success. GNC is here to be the helping hand with our knowledgeable coaches in our stores, our science-backed products, and expert education and resources on GNC.com.”
GNC also said its in-store “coaches” have received training related to the common side effects experienced by GLP-1 agonist users, and will continue to get training from the company’s in-house team of RDs and science experts.
The most reported side effect of GLP-1 drugs is a gastrointestinal issue like nausea or constipation.
The GNC support program extends to its website where consumers can find advice and health information fitness and resistance training, healthy recipes, meal plans, and more.
“The market is constantly evolving and at GNC, we are leading the way in product strategy and development to help our customers achieve their wellness goals especially for GLP-1 users,” said Rachel Jones, senior vice president, chief product innovation and science officer, GNC. “We’re not only responding to immediate needs but also continuously collaborating with medical experts to refine and expand our offerings to best serve our customers.”
